Navidea Biopharmaceuticals to Announce Third Quarter 2014 Financial Results on November 6, 2014 Oct 29, 2014
FDA Approves Expanded Use of Navidea’s Lymphoseek® for Lymphatic Mapping in Solid Tumors Oct 15, 2014
Navidea to Participate in the BTIG Emerging Technologies in Healthcare Diagnostics Investor Conference September 30th Sep 29, 2014
Navidea’s Lymphoseek® Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast and Certain Head and Neck Cancers Sep 26, 2014
Navidea Awarded $1.67M Fast Track NIH SBIR Grant for Evaluation of Lymphoseek® in Cervical Cancer Sep 23, 2014
Navidea Receives Orphan Drug Designation from FDA for Use of Lymphoseek® in Head and Neck Cancers Sep 18, 2014
Navidea Announces Second Quarter 2014 Financial Results; Total Revenues Grow to $1.1 Million Aug 6, 2014
Navidea Biopharmaceuticals to Announce Second Quarter 2014 Financial Results on August 6, 2014 Jul 29, 2014